Skip to main content

Advertisement

SpringerLink
Log in

Respiratory failure or impairment in amyotrophic lateral sclerosis

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

  • •Respiratory complications account for the majority of deaths occurring in patients suffering from amyotrophic lateral sclerosis (ALS). Patients normally succumb to their illness within an average of 3 to 5 years from the time of diagnosis from complications such as hypoventilation, hypoxemia, hypercarbia, aspiration, and other pneumonia and pulmonary emboli [1]. Although invariably disabling, ALS need not be fatal if respiratory involvement is detected early, which will allow sufficient time to discuss and implement treatment options. The recently published American Academy of Neurology guidelines for the management of ALS recommends the following:

  • •Serial measures of pulmonary function to guide management and determine prognosis.

  • •Noninvasive ventilatory support—an effective initial therapy for symptomatic chronic hypoventilation and prolonged survival.

  • •Invasive ventilatory support when long-term survival is the goal and noninvasive support is no longer sufficient.

  • •Physicians respect the right of the patient to choose, refuse, or withdraw ventilatory support.

  • •Liberal use of opiates and anxiolytics to relieve dyspnea and anxiety when ventilatory support is refused or withdrawn.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Fallat RJ, Jewitt B, Bass M, et al.: Spirometry in amyotrophic lateral sclerosis. Arch Neuro 1979, 36:74–80.

    CAS  Google Scholar 

  2. Smith PEM, Calverley PMA, Edwards RHT: Hypoxia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis 1988, 137:884.

    PubMed  CAS  Google Scholar 

  3. Miller RG, Rosenberg JA, Gelinas DF, et al.: Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1999, 52:1311–1323. A good evidence-based report from the American Academy of Neurology.

    PubMed  CAS  Google Scholar 

  4. Gibson GJ: Diaphragmatic paresis: pathophysiology clinical features and investigation. Thorax 1989, 4:960.

    Google Scholar 

  5. Kreitzer SM, Feldman NT, Saunders NA, et al.: Bilateral diaphragmatic paralysis with hypercapnic respiratory failure: a physiologic assessment. Am J Med 1978, 65:89.

    Article  PubMed  CAS  Google Scholar 

  6. Bye PT, Ellis ER, Issa FG, et al.: Respiratory failure and sleep in neuromuscular disease. Thorax 1990, 45:241.

    PubMed  CAS  Google Scholar 

  7. Grinman S, Whitelaw WA: Pattern of breathing in a case of generalized respiratory muscle weakness. Chest 1983, 84:770.

    PubMed  CAS  Google Scholar 

  8. Poponick JM, Jacobs I, Supinski G, DiMarco AF: Effect of upper respiratory tract infection in patients with neuromuscular disease. Am J Respir Crit Care Med 1997, 156:659–664.

    PubMed  CAS  Google Scholar 

  9. Mathus-Vliegen LMH, Louwerse LS, Merkus MP, et al.: Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc 1994, 40:463–469.

    Article  PubMed  CAS  Google Scholar 

  10. Mazzini L, Corra T, Zaccala M, et al.: Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. Neurology 1995, 242:695–698.

    Article  CAS  Google Scholar 

  11. Blasco PA, Stansbury JCK: Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996, 150:932–935.

    PubMed  CAS  Google Scholar 

  12. Stern LM: Preliminary study of glycopyrrolate in the management of drooling. J Padiatr Child Health 1997, 33:52–54.

    CAS  Google Scholar 

  13. Dworkin JP, Nadal JC: Nonsurgical treatment of drooling in a patient with closed head injury and severe dysarthria. Dysphagia 1991, 6:40–49.

    Article  PubMed  CAS  Google Scholar 

  14. Brodtkorb E, Wyzocka-Bakowska MM, Lillevold PE, et al.: Transdermal scopolamine in drooling. J Ment Def Res 1988, 32:233–237.

    Google Scholar 

  15. Lewis DW, Fontana C, Mehallick LK, Everett Y: Transdermal scopolamine for reductions in drooling in developmentally delayed children. Dev Med Child Neurol 1994, 36:484–486.

    Article  PubMed  CAS  Google Scholar 

  16. Newall AR, Orser R, Hunt M: The control of oral secretions in bulbar ALS/MND. J Neurol Sci 1996, 139:43–44.

    Article  PubMed  Google Scholar 

  17. Gelinas DF, Miller RG: A treatable disease: a guide to the management of anyotrophic lateral sclerosis. In Amyotrophic Lateral Sclerosis. Edited by Brown RH, Meininger V, Swash M. London: Martin Dunitz; 2000:405–421. A recent, well-written and thorough how-to guide for the management of amyotrophic lateral sclerosis.

    Google Scholar 

  18. Bach JR: Mechanical insufflation-exsufflation. Chest 1993, 4:1553–1562.

    Google Scholar 

  19. Voltz R, Borasio G: Palliative therapy in the terminal stage of neurologic disease. Neurology 1997, 244(suppl 4):S2-S10.

    Google Scholar 

  20. Ellis ER, Bye PTP, Bruderer JW, et al.: Treatment of respiratory failure during sleep in patients with neuromuscular disease. Am Rev Respir Dis 1987, 135:148–152.

    PubMed  CAS  Google Scholar 

  21. Bach JR, Alba AS: Management of chronic alveolar hypoventilation by nasal ventilation. Chest 1990, 97:52–57.

    PubMed  CAS  Google Scholar 

  22. Pinto A, Evangelista T, Carvalho M, et al.: Respiratory assistance with a non-invasive ventilator (BiPAP) in motor neuron disease/amyotrophic lateral sclerosis patients: survival rates in a controlled trial. J Neurol Sci, 129:19–26.

  23. Aboussan LS, Khan SU, Meeker DP, et al.: Effect of non-invasive positive pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997, 127:450–453.

    Google Scholar 

  24. Cazzolli PA, Oppenheimer EA: Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation. J Neurol Sci 1996, 139:123–128.

    Article  PubMed  Google Scholar 

  25. Borasio GD, Voltz R: Palliative care in amyotrophic lateral sclerosis, J Neurol 1997, 244(suppl 4):S11-S17.

    Article  PubMed  Google Scholar 

  26. Oppenheimer EA: Decision-making in the respiratory care of amyotrophic lateral sclerosis: should home mechanical ventilation be used? Palliat Med 1993, 7:49–64.

    Article  PubMed  CAS  Google Scholar 

  27. Make BJ, Gilmartin ME: Mechanical ventilation in the home. Crit Care Clin 1990, 6:785–797.

    PubMed  CAS  Google Scholar 

  28. Hayashi H, Kato S, Kawada A: Amyotrophic lateral sclerosis patients living beyond respiratory failure. J Neurol Sci 1991, 105:73–78.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, California Pacific Medical Center, 2324 Sacramento Street, Suite 150, 94115, San Francisco, CA, USA

    Deborah F. Gelanis MD

Authors
  1. Deborah F. Gelanis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gelanis, D.F. Respiratory failure or impairment in amyotrophic lateral sclerosis. Curr Treat Options Neurol 3, 133–138 (2001). https://doi.org/10.1007/s11940-001-0048-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-001-0048-z

Keywords

Search

Navigation